CLASS III ONGOING Drug recall · Reported 1 Apr 2026 · FDA Enforcement Report

Gelatin Capsule Pack for use recalled by Radnostix

Radnostix is recalling Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing and 300 mg, distributed nationwide in the US. The recall was initiated on 19 Feb 2026 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot, expiry: Lot 3666245, exp: 02/28/2026; Lot 4546213, exp: 02/28/2026 and Lot 4951280, exp 09/30/2027
NDC69208-000
Quantity recalled2,699 blister cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0401-2026
FDA event ID
98492
Recalling firm
Radnostix, Idaho Falls, ID
Manufacturer
Radnostix, Inc.
Classification
Class III
Status
Ongoing
Recall initiated
19 Feb 2026
FDA classified
20 Mar 2026
Reported
1 Apr 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

19 Feb 2026Recall initiated by company
20 Mar 2026Classified by FDA+29 days
1 Apr 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Tablet/Capsule Specifications

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003-25; 69208-003-35

Where it was distributed

Nationwide in the US, including Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Failed Tablet/Capsule Specifications

Which lots are affected?

Lot, expiry: Lot 3666245, exp: 02/28/2026; Lot 4546213, exp: 02/28/2026 and Lot 4951280, exp 09/30/2027

Where was it sold?

Nationwide in the US, including Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Radnostix

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IISodium Iodide (I-131) Solution, Therapeutic Oral recalled by RadnostixSodium Iodide I-131RadnostixParticulate MatterNationwide

Other Sodium Iodide I-131 recalls

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IISodium Iodide (I-131) Solution, Therapeutic Oral recalled by RadnostixSodium Iodide I-131RadnostixParticulate MatterNationwide
DrugCLASS IIISodium Iodide I, USP Diagnostic Oral recalled by Jubilant DraximageSodium Iodide I 131 DiagnosticJubilant DraximageOtherNationwide